Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone Disorder (CKD-MBD) and in ...

Colored x-ray of the pelvic region shows a fractured femur (red) caused by a fall. A lack of clinical trials and limited pharmaceutical options mean that management of this complication poses ...

The researchers found that with denosumab vs oral bisphosphonates, the risk for emergently treated hypocalcemia increased with worsening CKD stage. (HealthDay News) — For patients with chronic kidney ...

Chronic kidney disease (CKD) has emerged as a global health challenge, largely due to its profound impact on mineral metabolism. Disruption of the tightly regulated balance of phosphate, calcium and ...

Please provide your email address to receive an email when new articles are posted on . Patients with diabetes mellitus had higher aortic pulse wave velocity levels vs. patients without diabetes.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A coalition of leading international experts in nephrology, bone health, and musculoskeletal disease has released the first comprehensive Consensus ...

Findings showed treatment with Prolia significantly increased the risk of developing severe hypocalcemia compared with bisphosphonates, especially in patients with advanced CKD. In patients with ...

Credit: Getty Images In a study, intact parathyroid hormone levels below 60 and above 1500 pg/mL were associated with nearly double the risk of all-cause mortality. High or low levels of calcium, ...

The bisphosphonates are used widely in osteoporosis. In patients with stage 4 CKD, one small study found a modest increase in the bone density of the spine after 18 months, but no change in the hip. 7 ...